Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

This study has been terminated.
(not enough patients enrolled)
Sponsor:
Information provided by (Responsible Party):
Gerhard Rogler, University of Zurich
ClinicalTrials.gov Identifier:
NCT01012570
First received: November 11, 2009
Last updated: December 3, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)